Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 5.68
(1.25%)
CNY 5.68
(1.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.76 Billion CNY | -1.42% |
| 2022 | 2.8 Billion CNY | 11.86% |
| 2021 | 2.5 Billion CNY | 2.31% |
| 2020 | 2.45 Billion CNY | -16.44% |
| 2019 | 2.93 Billion CNY | -7.68% |
| 2018 | 3.17 Billion CNY | 4.4% |
| 2017 | 3.04 Billion CNY | 0.34% |
| 2016 | 3.03 Billion CNY | 7.09% |
| 2015 | 2.83 Billion CNY | 22.61% |
| 2014 | 2.31 Billion CNY | 11.83% |
| 2013 | 2.06 Billion CNY | 7.21% |
| 2012 | 1.92 Billion CNY | 4.0% |
| 2011 | 1.85 Billion CNY | 237.85% |
| 2010 | 548.52 Million CNY | 2.75% |
| 2009 | 533.86 Million CNY | 36.28% |
| 2008 | 391.74 Million CNY | 35.76% |
| 2007 | 288.56 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.63 Billion CNY | -3.61% |
| 2024 Q3 | 2.76 Billion CNY | 5.02% |
| 2024 Q1 | 2.72 Billion CNY | -1.35% |
| 2023 Q3 | 2.73 Billion CNY | -6.35% |
| 2023 Q2 | 2.92 Billion CNY | -4.64% |
| 2023 FY | 2.76 Billion CNY | -1.42% |
| 2023 Q1 | 3.06 Billion CNY | 9.28% |
| 2023 Q4 | 2.76 Billion CNY | 1.02% |
| 2022 Q4 | 2.8 Billion CNY | 1.27% |
| 2022 Q2 | 2.61 Billion CNY | -2.92% |
| 2022 FY | 2.8 Billion CNY | 11.86% |
| 2022 Q1 | 2.69 Billion CNY | 7.58% |
| 2022 Q3 | 2.77 Billion CNY | 5.76% |
| 2021 Q3 | 2.37 Billion CNY | 5.33% |
| 2021 Q1 | 2.36 Billion CNY | -3.51% |
| 2021 FY | 2.5 Billion CNY | 2.31% |
| 2021 Q4 | 2.5 Billion CNY | 5.84% |
| 2021 Q2 | 2.25 Billion CNY | -4.89% |
| 2020 Q2 | 2.77 Billion CNY | -0.46% |
| 2020 Q4 | 2.45 Billion CNY | -8.04% |
| 2020 Q1 | 2.78 Billion CNY | -5.16% |
| 2020 FY | 2.45 Billion CNY | -16.44% |
| 2020 Q3 | 2.66 Billion CNY | -3.75% |
| 2019 Q1 | 3.24 Billion CNY | 2.01% |
| 2019 Q4 | 2.93 Billion CNY | -3.4% |
| 2019 Q3 | 3.03 Billion CNY | -2.88% |
| 2019 Q2 | 3.12 Billion CNY | -3.53% |
| 2019 FY | 2.93 Billion CNY | -7.68% |
| 2018 Q3 | 3.26 Billion CNY | 0.9% |
| 2018 FY | 3.17 Billion CNY | 4.4% |
| 2018 Q2 | 3.23 Billion CNY | 4.87% |
| 2018 Q1 | 3.08 Billion CNY | 1.27% |
| 2018 Q4 | 3.17 Billion CNY | -2.56% |
| 2017 Q3 | 2.89 Billion CNY | -2.59% |
| 2017 Q1 | 2.99 Billion CNY | -1.16% |
| 2017 FY | 3.04 Billion CNY | 0.34% |
| 2017 Q2 | 2.97 Billion CNY | -0.87% |
| 2017 Q4 | 3.04 Billion CNY | 5.13% |
| 2016 Q2 | 2.84 Billion CNY | -1.27% |
| 2016 FY | 3.03 Billion CNY | 7.09% |
| 2016 Q1 | 2.88 Billion CNY | 1.74% |
| 2016 Q3 | 2.86 Billion CNY | 0.67% |
| 2016 Q4 | 3.03 Billion CNY | 5.9% |
| 2015 Q4 | 2.83 Billion CNY | 7.63% |
| 2015 Q3 | 2.63 Billion CNY | 7.61% |
| 2015 FY | 2.83 Billion CNY | 22.61% |
| 2015 Q1 | 2.33 Billion CNY | 0.92% |
| 2015 Q2 | 2.44 Billion CNY | 4.89% |
| 2014 Q3 | 2.16 Billion CNY | 4.81% |
| 2014 FY | 2.31 Billion CNY | 11.83% |
| 2014 Q4 | 2.31 Billion CNY | 6.74% |
| 2014 Q2 | 2.06 Billion CNY | -0.74% |
| 2014 Q1 | 2.08 Billion CNY | 0.71% |
| 2013 Q3 | 1.98 Billion CNY | 2.62% |
| 2013 Q4 | 2.06 Billion CNY | 4.22% |
| 2013 FY | 2.06 Billion CNY | 7.21% |
| 2013 Q1 | 1.96 Billion CNY | 1.76% |
| 2013 Q2 | 1.93 Billion CNY | -1.49% |
| 2012 Q3 | 1.91 Billion CNY | 0.03% |
| 2012 FY | 1.92 Billion CNY | 4.0% |
| 2012 Q1 | 1.84 Billion CNY | -0.23% |
| 2012 Q2 | 1.91 Billion CNY | 3.66% |
| 2012 Q4 | 1.92 Billion CNY | 0.53% |
| 2011 Q2 | 1.73 Billion CNY | -2.61% |
| 2011 FY | 1.85 Billion CNY | 237.85% |
| 2011 Q1 | 1.77 Billion CNY | 224.17% |
| 2011 Q3 | 1.8 Billion CNY | 4.05% |
| 2011 Q4 | 1.85 Billion CNY | 2.84% |
| 2010 Q3 | 508.4 Million CNY | -10.37% |
| 2010 FY | 548.52 Million CNY | 2.75% |
| 2010 Q2 | 567.2 Million CNY | 0.0% |
| 2010 Q4 | 548.52 Million CNY | 7.89% |
| 2009 FY | 533.86 Million CNY | 36.28% |
| 2009 Q4 | 533.86 Million CNY | 0.0% |
| 2008 FY | 391.74 Million CNY | 35.76% |
| 2007 FY | 288.56 Million CNY | 0.0% |